Intended Use

HepaFatSmart is intended for quantitative measurement of volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF), and steatosis grading using MRI.

Technology

HepaFatSmart is a cloud-based or onsite AI-assisted software that takes DICOM MRI datasets acquired via a specific GRE protocol; employs a convolutional neural network (CNN) for liver ROI detection; applies algorithmic modules to compute Alpha, VLFF, PDFF, steatosis grade, and assesses liver iron content; generates PDF and DICOM reports with quantitative fat measurements and quality images.

Performance

Performance evaluated via repeatability and validation studies (n=42, n=300) showed HepaFatSmart has excellent agreement and substantial equivalence with predicate HepaFat-Scan for liver fat fraction measurement, with improved repeatability and specificity/sensitivity over predicate HepaFat-AI. Clinical thresholds for steatosis grades were accurately predicted with sensitivities and specificities above 90%.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    5/19/2023

    1 month
  • 2

    FDA Approval

    6/20/2023

Other devices from Resonance Health Analysis Services Pty Ltd

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.